- GOQii has also recently partnered with German health-tech start-up Thryve to conduct a clinical study for early detection of COVID-19 infections based on data collected from the Smart Vital
- GOQii plans to run trials with hospitals across India to establish the platform as a critical monitoring tool for COVID-19 treatment centres across the globe
- Countries around the world are adopting wearable technology to contain the spread of COVID-19 infections, including the US, UK, Israel, and Singapore.
GOQii, the smart-tech preventive healthcare company, and K.J. Somaiya Medical College and Research Centre have announced a seminal clinical study on the use of advanced wearable technology to provide doctors and medical staff with detailed health data on each patient under their care in real-time. The GOQii Smart Vital that was recently launched and has been heralded as a world’s first disruption, enabling remote patient management at scale. The smart band can track vitals like Body Temperature, Heart Rate, Blood Pressure and SPO2, while keeping a check on your step count and calories. The GOQii platform processes all this data (in compliance with all relevant data protection regulation) and enables hospital administrators, doctors, nurses, and medical staff to see a centralized dashboard displaying the vitals of all those tracked on the platform.
In the current time, there is an urgent need for the start-up and technology communities around the world to innovate around solutions for the COVID-19 pandemic. The development of rapid wearable diagnostic tools to identify and isolate COVID-19 cases, as well as solutions for remote management of patients, will be critical to humanity’s long-term success against the virus. GOQii is already working with Thryve, the German Government’s health-tech partner, to conduct a clinical study in India on using wearable technology to predict all types of diseases, including COVID-19.
“K.J. Somaiya Medical College & Research Centre prides itself in springing to action in the beginning stages of the COVID-19 infection spread. Even during these times, we aim to provide the highest standard of healthcare to those that seek treatment in our facilities. Through innovative wearable technology, like GOQii’s product, we aim to further our understanding of the deadly coronavirus and do our part to reduce its toll on our country,” said Dr. Varsha Phadke, Dean of K.J Somaiya Medical College.
Through this research, GOQii aims to establish itself as a leader in remote patient management, especially in the context of COVID-19 treatment. During the trial, the company’s Smart Vital will be used in COVID wards eventually to be used as a first layer of protection against the coronavirus for frontline workers including doctors, nurses and other hospital staff. The GOQii Platform will also be used by these same frontline workers to monitor the vitals of asymptomatic and suspected cases of COVID-19 infection through a computer or mobile application in real-time.
“We are delighted to have the opportunity to showcase our flagship product as a remote patient management solution for COVID-19 infection screening and monitoring. The K.J. Somaiya Medical College & Research Centre is an ideal partner, that has been recognized nationally for its efforts in providing excellent healthcare during this COVID-19 crisis. We look forward to providing a blueprint for innovation in wearable sensor technology use in the fight against COVID-19.” said, Vishal Gondal, Founder & CEO of GOQii
Many well-respected medical journals have published research on the use of wearable technology to screen cases of disease. The Lancet, the world’s oldest and best-known general medicine journal, published a study this year that found heart rate from wearable data sources can indicate flu-like illness. Researchers went on to conclude that it could be possible to improve real-time and geographically refined influenza surveillance. The information could be vital to enact timely outbreak response measures to prevent further transmission of influenza cases during outbreaks.
Researchers at the Stanford University School of Medicine and the Scripps Translational Research Institute are already training algorithms to find early warning signs of COVID-19 and other infections using healthcare data from wearable technology. They have already begun clinical trials on users of wearable devices after demonstrating potential in the technology.
PLOS Biology, the first peer-reviewed journal from the acclaimed Public Library of Science, published research positing a connection between resting heart rate and skin temperature and disease diagnosis. One of the co-authors, Mr. Michael Snyder, a professor of genetics and director of the Center for Genomics and Personalized Medicine at Stanford University, in his review said, ‘ We think your smartwatch tells you when you’re getting ill before you know it”.
|Category/Study Name||1st Data Source(s)||Institution(s)||Country|
|GOQii Platform||Smartwatch: activity, skin temperature, heart rate and sleep||Thryve, Somaiya Hospital||India|
|DETECT Study and COVID-19 Wearables||Smartwatch, smart ring, EHR||Scripps, Stanford||US|
|COVID-19 Citizen Science||Smartphone +||UCSF||US|
|Corona-Datenspende App||Smartwatch, body temp||Robert Koch Institute and Thryve Digital||Germany|
|Symptom Checkers||Multiple smartphone apps with daily inputs||NA||Israel, UK, Canada, Switzerland, Germany|
|Aggregated Mobility/Geolocation||Cellphone||NA||Germany, China and other Asia, EU countries|
|PACT (Private Automatic Contact Tracing)||Smartphone||MIT, CSAIL||US|